Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

48.52
+0.08000.17%
Volume:61.05K
Turnover:2.95M
Market Cap:1.65B
PE:23.32
High:48.84
Open:48.79
Low:47.85
Close:48.44
52wk High:60.00
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:1.10
T/O Rate:0.22%
Dividend:2.99
Dividend Rate:6.16%
EPS(TTM):2.08
EPS(LYR):2.41
ROE:13.77%
ROA:3.98%
PB:2.72
PE(LYR):20.13

Loading ...

Buy Rating on West: Strong Non‑GLP‑1 Growth, Margin Expansion, and Regulatory Tailwinds Support 2026 Outlook

TIPRANKS
·
1 hour ago

West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns

TIPRANKS
·
Yesterday

Global Partners LP to Announce Fourth-Quarter and Full-Year 2025 Financial Results

Reuters
·
Yesterday

McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge

Benzinga_recent_news
·
Yesterday

Veru Inc. Charts Risky but Clearer Post-GLP-1 Path

TIPRANKS
·
Yesterday

Edible Garden to Introduce Clean-Label JEALOUSY GLP-1 Support System and New Kick. Sports Nutrition® Innovations at ECRM Total Wellness Session

GlobeNewswire
·
Feb 11

Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

GlobeNewswire
·
Feb 10

Regulatory Overhang on Compounded GLP‑1 Drives Hold Rating and Lowered Outlook for Hims & Hers

TIPRANKS
·
Feb 09

Dow Jones Top Company Headlines at 1 AM ET: Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department | Innovent ...

Dow Jones
·
Feb 09

Dow Jones Top Company Headlines at 7 PM ET: FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs | Justice ...

Dow Jones
·
Feb 07

FDA intends to ‘take action’ against non-FDA-approved GLP-1 drugs

TIPRANKS
·
Feb 07

Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target

TIPRANKS
·
Feb 06

LifeVantage Earnings Call: GLP-1 Hit Tests Turnaround

TIPRANKS
·
Feb 06

Edible Garden to Participate in ECRM’s Total Wellness: GLP-1, Weight Management, Nutrition & Vitamin Session, February 10–12, 2026

GlobeNewswire
·
Feb 05

Press Release: GLP China Holdings Limited TENDER OFFER TO PURCHASE FOR CASH ANY AND ALL OF ITS U.S.$700,000,000 2.95 PER CENT. NOTES DUE 2026

Dow Jones
·
Feb 05

PepsiCo Charts Growth Amid GLP-1, Ad Headwinds

TIPRANKS
·
Feb 04

Is It Time To Reassess Global Partners (GLP) After Big Five Year Share Gains?

Simply Wall St.
·
Jan 31

Press Release: Global Partners Declares Fourth-Quarter 2025 Cash Distribution of $0.7600 on Common Units

Dow Jones
·
Jan 30

Fractyl Health Advances Revita for Post-GLP-1 Weight Maintenance

TIPRANKS
·
Jan 29

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

GlobeNewswire
·
Jan 28